Literature DB >> 11044796

Normative data for total and free acid-labile subunit of the human insulin-like growth factor-binding protein complex in pre- and full-term newborns and healthy boys and girls throughout postnatal development.

V Barrios1, J Pozo, M T Muñoz, M Buño, J Argente.   

Abstract

Insulin-like growth factors (IGFs) circulate in plasma as part of a 150-kD complex that also contains IGF-binding protein-3 (IGFBP-3), a protein that binds IGF-I and IGF-II with high affinity, and an acid-labile subunit (ALS) that does not directly bind IGFs. Because the ALS assay methods currently being used are relatively new, there is a need for updated normative reference data. We report the normative data in 17 preterm infants (10 males and 7 females), 30 normal full-term newborns (15 males and 15 females) and 150 normal children who where divided into 5 groups according to their Tanner stage (15 males and 15 females per group). Serum levels of total and free ALS were significantly lower in premature infants than in full-term newborns, but all newborns had significantly lower levels than Tanner stage-I children (p<0.001, ANOVA). A significant increase was seen between Tanner stages I-III in both sexes (p<0.001, ANOVA). No differences were found between sexes at any developmental age studied. Significant correlations (p<0.001) were seen between total and free ALS concentrations and IGF-I (r = 0.50 and 0.60, respectively), free IGF-I (r = 0.37 and 0.36), IGF-II (r = 0.37 and 0.27), IGFBP-1 (r = -0.48 and -0.49), IGFBP-2 (r = -0.44 and -0.51) and IGFBP-3 (r = 0.67 and 0.59) at all Tanner stages. However, no correlation was found with IGFBP-1, -2 or -3 levels at birth. This study shows normal values in a population of preterm infants and healthy Spanish newborns and subjects of both sexes at all stages of pubertal development and indicate the different relationships between the components of the IGF system during intra- and extrauterine life. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11044796     DOI: 10.1159/000023554

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  4 in total

1.  Determining the normal range for IGF-I, IGFBP-3, and ALS: new reference data based on current internal standards.

Authors:  Diana-Alexandra Ertl; Andreas Gleiss; Susanne Sagmeister; Gabriele Haeusler
Journal:  Wien Med Wochenschr       Date:  2014-09-04

2.  Effect of recombinant growth hormone on leptin, adiponectin, resistin, interleukin-6, tumor necrosis factor-α and ghrelin levels in growth hormone-deficient children.

Authors:  J P López-Siguero; L F López-Canti; R Espino; E Caro; J M Fernández-García; A Gutiérrez-Macías; J M Rial; J L Lechuga; F Macías; M J Martínez-Aedo; S Rico; I Rodríguez; J Guillén; F J Arroyo; S Bernal; R Espigares; M Núñez; A Escribano; J L Barrionuevo; J Gentil; V Barrios; A Fernández-Nistal; G A Martos-Moreno; V Martínez; J Argente
Journal:  J Endocrinol Invest       Date:  2010-07-13       Impact factor: 4.256

3.  Low postnatal serum IGF-I levels are associated with bronchopulmonary dysplasia (BPD).

Authors:  Chatarina Löfqvist; Gunnel Hellgren; Aimon Niklasson; Eva Engström; David Ley; Ingrid Hansen-Pupp
Journal:  Acta Paediatr       Date:  2012-09-10       Impact factor: 2.299

Review 4.  Insulin-like growth factor 1 has multisystem effects on foetal and preterm infant development.

Authors:  Ann Hellström; David Ley; Ingrid Hansen-Pupp; Boubou Hallberg; Chatarina Löfqvist; Linda van Marter; Mirjam van Weissenbruch; Luca A Ramenghi; Kathryn Beardsall; David Dunger; Anna-Lena Hård; Lois E H Smith
Journal:  Acta Paediatr       Date:  2016-03-08       Impact factor: 2.299

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.